RenovoRx Begins Post-market Registry Study
RenovoRx has announced the opening of its post-market registry study, which will assess patient survival and clinical outcomes of the RenovoCath catheter when used to deliver gemcitabine and other chemotherapeutic agents to pancreatic tumors. The study will include up to 10 medical centers across the U.S. and will follow up to 100 patients with locally […]
RenovoRx Begins Post-market Registry Study
RenovoRx has announced the opening of its post-market registry study, which will assess patient survival and clinical outcomes of the RenovoCath catheter when used to deliver gemcitabine and other chemotherapeutic agents to pancreatic tumors. The study will include up to 10 medical centers across the U.S. and will follow up to 100 patients with locally […]